Galderma (BX:GALD) Added to SMI; Raises 2026 Sales Growth Guide
Galderma joined the Swiss Market Index and raised its 2026 net sales growth guidance to 19—21% at constant currency, from 17—20%, while reaffirming a Core EBITDA margin of approximately 26% at constant currency.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of accelerating gr…